CPIX — CUMBERLAND PHARMACEUTICALS INC
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1087294 ·
Last close
$7.61
Market Cap
$114.02M
52W High
$9.28
52W Low
$1.43
ADV30
61,990
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 9,131,317 | 7,197,428 | -3,129,292 | -3,289,639 | 70,995,020 | 11,007,245 | 49,692,008 |
| Dec 2025 | 13,678,651 | 11,437,307 | -1,371,202 | -1,411,692 | 76,823,992 | 11,444,693 | 52,279,770 |
| Sep 2025 | 8,292,362 | 7,303,602 | -1,965,260 | -1,940,764 | 65,898,560 | 15,196,745 | 40,097,856 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,421,029
Investing CF
$-3,539,484
Financing CF
$-1,982,714
CapEx
$-1,323,419
Dividends Paid
—
Buybacks
$-78,611
EPS Diluted TTM
$-0.71
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-30,093,698
Inventory
$5,453,836
Receivables
$14,261,978
ST Investments
—
EBIT TTM
$-6,784,162
Pretax Income TTM
$-7,202,189
Interest Exp TTM
$418,027
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$44,304,312
EBITDA
$1,096,723
Free Cash Flow
$-191,169
Enterprise Value
$96,262,272
Total Cash
$3,862,402
Total Debt
$4,714,184
Shares Out
14,983,107
Trailing EPS
$-0.22
Book Value
$1.16
ROE
-14.4%
ROA
-2.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 44,521,431 | -2,791,993 | -2,836,128 | 76,823,992 | 52,279,770 | 24,880,322 | 4,932,522 |
| Dec 2024 | 37,867,945 | -6,432,409 | -6,479,770 | 75,583,410 | 53,037,433 | 22,853,494 | -612,186 |
| Dec 2023 | 39,552,507 | -9,554,661 | -6,279,320 | 81,776,075 | 52,516,206 | 29,603,441 | 6,093,821 |
| Dec 2022 | 42,010,949 | -5,704,929 | -5,570,241 | 92,925,158 | 56,951,152 | 36,266,132 | 8,453,396 |
TTM Snapshot
Revenues TTM
$43,588,732
NetIncome TTM
$2,437,190
OpCashFlow TTM
$0
Assets (Latest)
$76,823,992
Forward EPS
$0.14
Max Pain — expiry 2026-10-16
max pain strike: $5.00 · spot: $7.84 · call oi: 2,117 · put oi: 122
Expected Move to 2026-10-16:
±$2.20
(28.08%) —
implied range
$5.64 –
$10.04
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| QUCY | Quantum Cyber N.V. | $115.17M | $1.37 | — |
| GNLX | GENELUX Corp | $112.21M | $2.48 | — |
| CTOR | CITIUS ONCOLOGY, INC. | $111.05M | $1.05 | — |
| AARD | Aardvark Therapeutics, Inc. | $110.74M | $5.06 | — |
| OKUR | OnKure Therapeutics, Inc. | $117.44M | $2.90 | — |
News headlines (Yahoo Finance, 1h cache)
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS
2026-07-28 20:05 · Yahoo
/C O R R E C T I O N -- Cumberland Pharmaceuticals Inc./
2026-07-13 15:20 · Yahoo
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals
2026-07-01 13:00 · Yahoo
Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex
2026-07-01 13:00 · Yahoo
Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference
2026-06-26 15:00 · Yahoo
Cumberland Posts Loss in Q1 Amid $100M Apotex Deal Plan
2026-05-06 14:12 · Yahoo
Cumberland Pharmaceuticals Q1 Earnings Call Highlights
2026-05-05 23:43 · Yahoo
Cumberland Pharmaceuticals Inc. Q1 2026 Earnings Call Summary
2026-05-06 12:30 · Yahoo
The Zacks Analyst Blog Highlights Alphabet, Apple, Micron Technology, Cumberland Pharmaceuticals and AmeriServ Financial
2026-05-28 10:15 · Yahoo
Cumberland Pharmaceuticals Inc (CPIX) (Q2 2026) Earnings Call Highlights: Strategic ...
2026-08-05 05:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.